Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and Outcomes.
Dario BarattiShigeki KusamuraMarcello GuaglioMassimo MilioneFilippo PietrantonioTommaso CavalleriFederica MoranoMarcello DeracoPublished in: Annals of surgical oncology (2022)
Relapse after CRS/HIPEC most commonly involves the peritoneum, but pleural recurrences and systemic metastases occur in a small but clinically relevant number of patients. In selected patients, surgical resection of recurrent disease can result in long survival, irrespective of sites of failure.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- type diabetes
- peritoneal dialysis
- minimally invasive
- adipose tissue
- metabolic syndrome
- acute coronary syndrome
- patient reported outcomes
- skeletal muscle
- coronary artery disease
- insulin resistance
- weight loss
- drug induced